Assembly Biosciences ASMB Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Efficiency | |||||
| Asset turnover | 0.4×+0.2× | 0.2×+0.2× | 0.1×— | 0×— | |
| Liquidity | |||||
| Current ratio | 5.2×+2.8× | 2.4×-1.0× | 3.4×-2.5× | 6×-3.6× | |
| Leverage | |||||
| Debt-to-equity | 0×-0.1× | 0.1×0.0× | 0.1×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $18.44+232% | $5.56-38.1% | $8.98-56.2% | $20.49+425% | |
| Valuation | |||||
| Market capitalization | $480.77M+262% | $100.3M+85.9% | $53.96M-14.9% | $63.41M-43.1% | |
| Price / sales | 6.8×+2.6× | 3.5×-4.0× | 7.5×— | —— | |
| Price / book | 2.4×-2.5× | 3×+1.7× | 1.3×+0.5× | 0.8×+0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Assembly Biosciences's ratios come from?
- Every ratio is computed from Assembly Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
